Evidence map›Paper›PMID 11089878›Full record

ArticleClinical & experimental metastasis1999

Autocrine motility factor (neuroleukin, phosphohexose isomerase) induces cell movement through 12-lipoxygenase-dependent tyrosine phosphorylation and serine dephosphorylation events.

J Timár, S Tóth, J Tóvári, S Paku, A Raz

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical & experimental metastasis, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Differential expression of growth factors at the cellular level in virus-infected brain.Proceedings of the National Academy of Sciences of the United States of America · 2003
    Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

J TimárDepartment of Tumor Progression, National Institute of Oncology, Budapest, Hungary. jtimar@oncol.hu
S Tóth
J Tóvári
S Paku
A Raz
National Institute of Oncology · HUSemmelweis University · HUThe Barbara Ann Karmanos Cancer Institute · US

Funding

MOTILITY FACTOR RECEPTORR01CA051714 · NCI · WAYNE STATE UNIVERSITY · PI RAZ, AVRAHAM · 1991 to 2012
$3.8M
NCI NIH HHS CA51714-08
6 · The paper itself

Abstract

Autocrine motility factor (AMF) is one of the motility cytokines regulating tumor cell migration, therefore identification of the signaling pathway coupled with it has critical importance. Previous studies revealed several elements of this pathway predominated by lipoxygenase-PKC activations but the role for tyrosine kinases remained questionable. Motility cytokines frequently have mitogenic effect as well, producing activation of overlapping signaling pathways therefore we have used B16a melanoma cells as models where AMF has exclusive motility effect. Our studies revealed that in B16a cells AMF initiated rapid (1-5 min) activation of the protein tyrosine kinase (PTK) cascade inducing phosphorylation of 179, 125, 95 and 40/37 kD proteins which was mediated by upstream cyclo- and lipoxygenases. The phosphorylated proteins were localized to the cortical actin-stress fiber attachment zones in situ by confocal microscopy. On the other hand, AMF receptor activation induced significant decrease in overall serine-phosphorylation level of cellular proteins accompanied by serine phosphorylation of 200, 90, 78 and 65 kd proteins. The decrease in serine phosphorylation was independent of PTKs, PKC as well as cyclo- and lipoxygenases. However, AMF induced robust translocation of PKCalpha to the stress fibers and cortical actin suggesting a critical role for this kinase in the generation of the motility signal. Based on the significant decrease in serine phosphorylation after AMF stimulus in B16a cells we postulated the involvement of putative serine/threonine phosphatase(s) upstream lipoxygenase and activation of the protein tyrosine kinase cascade downstream cyclo- and lipoxygenase(s) in the previously identified autocrine motility signal.

Indexed as

ActinsAnimalsCell MovementEnzyme InhibitorsGlucose-6-Phosphate IsomeraseIsoenzymesLipoxygenaseLipoxygenase InhibitorsMelanomaMiceMicroscopy, ConfocalPhosphorylationProtein Kinase CProtein Kinase C-alphaProteinsSerineActinsEnzyme InhibitorsGlucose-6-Phosphate IsomeraseIsoenzymesLipoxygenaseLipoxygenase InhibitorsPrkca protein, mouseProtein Kinase CProtein Kinase C-alphaProteinsSerineTyrosine

Identifiers

PMID11089878
OpenAlexW209026648

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.